Drzeniek Z, Lamerz R, Fenger U, Wagener C, Haubeck H D
Institute for Clinical Chemistry and Pathobiochemistry, Medical Faculty, Technical University, Aachen, F.R.G.
Cancer Lett. 1991 Feb;56(2):173-9. doi: 10.1016/0304-3835(91)90093-w.
The gene coding for 'biliary glycoprotein (BGP)' is a member of the carcinoembryonic antigen (CEA) gene family. A monoclonal antibody (MAb) was induced against a BGP-preparation isolated from human bile. The antibody did not crossreact with the carcinoembryonic antigen (CEA) and different non-specific crossreacting antigens. The anti-BGP MAb was used to identify BGP-related antigens in membrane extracts from granulocytes and the colonic carcinoma cell line HT-29. In granulocyte membranes, a single antigen of Mr 160,000 was bound. In membranes from HT-29 cells, a main antigen of Mr 85,000 was present. At high antigen concentration, an additional antigen of Mr 115,000 was identified. Since several transcripts of the BGP gene have been identified, the different BGP related antigens are probably products of alternatively spliced mRNAs.
编码“胆汁糖蛋白(BGP)”的基因是癌胚抗原(CEA)基因家族的成员。针对从人胆汁中分离出的BGP制剂诱导产生了一种单克隆抗体(MAb)。该抗体与癌胚抗原(CEA)及不同的非特异性交叉反应抗原不发生交叉反应。抗BGP单克隆抗体用于鉴定粒细胞和结肠癌细胞系HT - 29膜提取物中的BGP相关抗原。在粒细胞膜中,结合了一种分子量为160,000的单一抗原。在HT - 29细胞膜中,存在一种分子量为85,000的主要抗原。在高抗原浓度下,鉴定出一种分子量为115,000的额外抗原。由于已鉴定出BGP基因的几种转录本,不同的BGP相关抗原可能是选择性剪接mRNA的产物。